Agile Therapeutics, Inc. Total Long-Term Debt
Agile Therapeutics, Inc. had Total Long-Term Debt of $1.51 million as of 2023-12-31, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2024-08-12
- 2023-12-31: Long-term Debt $1.51M.
- 2023-09-30: Long-term Debt $1.59M.
- 2023-06-30: Long-term Debt $1.56M.
- 2023-03-31: Long-term Debt $1.51M.
| Period end | Long-term Debt |
|---|---|
| 2023-12-31 | $1.51M 10-Q · filed 2024-08-12 |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.56M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.51M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.43M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.32M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $12.63M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $12.25M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $16.83M 10-K · filed 2023-03-23 |
| 2021-09-30 | $16.43M 10-Q/A · filed 2021-12-30 |
| 2021-06-30 | $16.04M 10-Q · filed 2021-07-26 |
| 2021-03-31 | $15.64M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $16.38M 10-K · filed 2022-03-30 |
| 2020-09-30 | $16.08M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $15.78M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $15.47M 10-Q · filed 2020-05-05 |